Compare BNR & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNR | FINW |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.9M | 194.1M |
| IPO Year | 2019 | 2021 |
| Metric | BNR | FINW |
|---|---|---|
| Price | $12.53 | $10.67 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.33 |
| AVG Volume (30 Days) | 28.2K | ★ 29.8K |
| Earning Date | 11-19-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.51 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | N/A |
| Revenue This Year | $101.46 | $41.06 |
| Revenue Next Year | $14.81 | $15.47 |
| P/E Ratio | ★ N/A | $30.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.79 | $10.49 |
| 52 Week High | $41.72 | $19.86 |
| Indicator | BNR | FINW |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 21.44 |
| Support Level | $8.91 | N/A |
| Resistance Level | $12.89 | $14.55 |
| Average True Range (ATR) | 1.50 | 0.29 |
| MACD | -0.63 | 0.05 |
| Stochastic Oscillator | 7.29 | 19.49 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.